You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV, new diagnosis, Biktarvy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Barcelona (Biktarvy)

Recruiting
  • HIV-1-infection
  • Barcelona, Spain
    Hospital Clínic de Barcelona
Dec 16, 2021

HIV, Renal Transplant Rejection Trial in New York (BIKTARVY 50Mg-200Mg-25Mg Tablet)

Recruiting
  • HIV Infections
  • Renal Transplant Rejection
  • BIKTARVY 50Mg-200Mg-25Mg Tablet
  • New York, New York
    Weill Cornell Medicine
Aug 1, 2022

Human Immunodeficiency Virus Trial in Newark (Dolutegravir/Lamivudine)

Active, not recruiting
  • Human Immunodeficiency Virus
  • Newark, New Jersey
    Saint Michael's Medical Center
May 3, 2022

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

Human Immunodeficiency Virus Trial in Brighton, London (Biktarvy, Symtuza)

Recruiting
  • Human Immunodeficiency Virus
  • Brighton, United Kingdom
  • +2 more
Jun 14, 2021

New Stool Based qPCR for Diagnosis of Tuberculosis in Children

Recruiting
  • Tuberculosis
  • Diagnoses Disease
    • Manhiça, Maputo, Mozambique
    • +2 more
    May 4, 2022

    Acute HIV Infection Trial in Brazil, Peru, United States (biological, other, drug)

    Not yet recruiting
    • Acute HIV Infection
    • VRC07-523LS
    • +3 more
    • Birmingham, Alabama
    • +35 more
    Jan 30, 2023

    HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

    Active, not recruiting
    • HIV Infections
    • Cabotegravir Tablets
    • +4 more
    • Bakersfield, California
    • +116 more
    Jan 22, 2023

    HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

    Recruiting
    • HIV/AIDS
    • Antwerp, Belgium
    • +47 more
    Jan 9, 2023

    HIV-1 Infection Trial in Worldwide (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or

    Active, not recruiting
    Has Results
    • HIV-1 Infection
    • elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
    • Birmingham, Alabama
    • +29 more
    Jan 24, 2022

    HIV-1 Infection Trial in United States (ISL, LEN, B/F/TAF)

    Active, not recruiting
    • HIV-1 Infection
    • Los Angeles, California
    • +23 more
    Jul 12, 2022

    HIV-1-infection Trial in Liuzhou, Najing, Tianjin (B/F/TAF, TDF/3TC/EFV)

    Recruiting
    • HIV-1-infection
    • Liuzhou, Guangxi, China
    • +2 more
    Mar 31, 2022

    Tuberculosis, COVID-19, HIV Trial in Cape Town, Lusaka, Harare (CAD, Xpert)

    Recruiting
    • Tuberculosis
    • +2 more
    • CAD
    • Xpert
    • Cape Town, Western Cape, South Africa
    • +2 more
    Mar 25, 2022

    HIV Trial in American Samoa, Australia, United States (MRKAd5 HIV-1 gag/pol/nef, MRKAd5 HIV-1 gag/pol/nef )

    Completed
    • HIV Infections
    • MRKAd5 HIV-1 gag/pol/nef
    • MRKAd5 HIV-1 gag/pol/nef placebo
    • San Diego, California
    • +22 more
    Oct 28, 2021

    Anal High Grade Squamous Intraepithelial Lesion Trial in New York, Houston (mHRME (Mobile High resolution microendoscope))

    Recruiting
    • Anal High Grade Squamous Intraepithelial Lesion
    • mHRME (Mobile High resolution microendoscope)
    • New York, New York
    • +1 more
    Sep 7, 2021

    HIV-1/HBV Co-Infection Trial in Worldwide (B/F/TAF, Placebo to match DTG, Placebo to match F/TDF)

    Active, not recruiting
    • HIV-1/HBV Co-Infection
    • Fort Pierce, Florida
    • +66 more
    Sep 19, 2022

    HIV Infection, Combined Antiretroviral Therapy Trial in Hangzhou

    Recruiting
    • HIV Infection
    • Combined Antiretroviral Therapy
      • Hangzhou, Zhejiang, China
        Zhikai Wan
      Aug 30, 2023

      HIV Trial in Madrid (Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY])

      Not yet recruiting
      • HIV Infections
      • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
      • Madrid, Spain
        H. Infanta Leonor
      Jun 2, 2022

      HIV-1 Infection Trial in Worldwide (DTG, F/TAF, B/F/TAF)

      Completed
      Has Results
      • HIV-1 Infection
      • Phoenix, Arizona
      • +124 more
      Feb 10, 2022

      HIV, Syphilis Trial in Baltimore (Cepheid GeneXpert HIV-1 Qual POC HIV VL test, DPP HIV-Syphilis test system, OraQuick)

      Recruiting
      • HIV Infections
      • Syphilis
      • Cepheid GeneXpert HIV-1 Qual POC HIV VL test
      • +2 more
      • Baltimore, Maryland
      • +2 more
      Aug 9, 2022

      Human Immunodeficiency Virus Trial in Oakland Park (bictegravir/emtricitabine/tenofovir alafenamide)

      Completed
      • Human Immunodeficiency Virus
      • bictegravir/emtricitabine/tenofovir alafenamide
      • Oakland Park, Florida
        Midland Research Group, Inc
      Feb 23, 2021

      Substance Abuse Trial in New York (Patient-administered screening tool, Patient health navigator-administered screening tool,

      Completed
      • Substance Abuse
      • Patient-administered screening tool
      • +2 more
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jul 29, 2020

      HIV Trial in Taipei (Bictegravir / Emtricitabine / Tenofovir Alafenamide Oral Tablet [Biktarvy])

      Recruiting
      • HIV Infections
      • Bictegravir / Emtricitabine / Tenofovir Alafenamide Oral Tablet [Biktarvy]
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jan 14, 2021

      HIV, Other STIs Trial in Boston, Roxbury, Bronx (Dada Kwa Dada (individual-level), DADA (group-level))

      Not yet recruiting
      • HIV
      • Other STIs
      • Dada Kwa Dada (individual-level)
      • DADA (group-level)
      • Boston, Massachusetts
      • +2 more
      Aug 28, 2023

      HIV/AIDS Trial in Aurora, Omaha (bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF), Standard initiation of

      Unknown status
      • HIV/AIDS
      • bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF)
      • Standard initiation of antiretroviral therapy (ART)
      • Aurora, Colorado
      • +2 more
      Dec 16, 2020